From Merck’s new licensing agreement to surgical study data being touted, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Merck inks exclusive licensing agreement for Alzheimer’s antibody Merck announced in a May 25 press release that it has entered an exclusive worldwide license agreement with Teijin Pharma. […]
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
The FDA slapped Midmark Corp. with a "significant" warning letter after an inspection of its Versailles, Ohio, headquarters last year.
The laundry list of violations from the watchdog agency focused primarily on manufacturing procedures and record-keeping issues related to the company’s steam sterilizer systems.
In one violation, deemed "significant" by the FDA, the health care device maker company failed to file a report after it realized the M11 steam sterilizer door could blow open during use.